Why BioNTech's Stock Is Trading Higher Today

Loading...
Loading...

BioNTech SE BNTX shares are trading higher on Thursday, after the company said it would partner with Pfizer PFE to initiate first clinical trials of the coronavirus vaccine as early as this month.

The company will receive $185 million upfront and is eligible for up to $563 million in milestones.

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases.

BioNTech SE shares were trading up 8.39% at $48.72 on Thursday. The stock has a 52-week high of $105 and a 52-week low of $12.52.

Posted In: BiotechNewsGeneralwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...